在关节骨折后口服双酸盐使用的轨迹:基于人口的队列研究
Miriam T Y Leung1, Justin P Turner2,3,4,5, Clara Marquina2
1Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Melbourne, VIC, 3052, Australia. miriam.leung77@monash.edu.
概括
许多关节骨折患者经历了延迟的双酸盐开始或早期停止治疗. 解决治疗犹和确保持续监测对于有效的骨质疏松症管理至关重要.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 双酸盐对于预防部骨折患者的二次骨折至关重要.
- 在关节骨折后使用非最佳的抗吸收药物仍然是令人担忧的.
- 了解坚持模式是改善骨质疏松症管理的关键.
研究的目的:
- 为了研究口服双酸使用轨迹后部骨折.
- 确定与双酸盐治疗的坚持和持续性相关的因素.
主要方法:
- 在澳大利亚维多利亚州 (Victoria,澳大利亚) 进行了年龄≥50岁患者的回顾性研究 (2012-2017年).
- 基于小组的轨迹建模,以对12个月的双酸盐使用模式进行分类.
- 多变量逻辑回归用于评估与不同轨迹相关的因素.
主要成果:
- 66%的患者表现出持续的坚持;17%的患者推迟了开药;9%的患者提前停药;9%的患者迟迟停药.
- 服用前使用双酸盐和年龄较大 (≥85) 降低了发药延迟的风险.
- 男性的焦虑和女性之前的跌倒增加了早期停止治疗的风险.
结论:
- 三分之二的关节骨折患者在12个月内坚持服用口服双酸盐.
- 改善抗吸收剂使用的策略应该是性别特定的.
- 解决治疗开始的不确定性对于改善骨折后护理至关重要.
更多相关视频
09:02Cortical Bone Assessment Using Ultrasonic Guided Waves: A Reproducibility Study in a Healthy Population
Published on: January 31, 2025
486
09:51The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
2.6K
相关概念视频
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Fractures: Bone Repair
3.2K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.2K
